Resumen

APARICIO HERNANDEZ, R.; GARCIA LUQUE, A.; GONZALO SALADO, M.ªH.  y  CABANES MARISCAL, M.A.. Positive assessment of drugs: september/October/November 2015. Sanid. Mil. [online]. 2016, vol.72, n.1, pp.42-52. ISSN 1887-8571.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in September, October and November of 2015, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palabras clave : Asparaginasa; Spectrila^®; Blinatumomab; Blincyto^®; Brivaracetam; Brivi^®; Carfilzomib; Kyprolis^®; Cobimetinib; Cotellic^®; Efmoroctocog alfa; Elocta^®; Elvitegravir/Cobicistat/Emtricitabina/Tenofovir Alafenamida; Genvoya^®; Etanercept; Benepali^®; Extracto de corteza de abedul; Episalvan^®; Fenilbutirato de glycerol; Ravicti^®; Fentanilo; Ionsys^®; Idarucizumab; Praxbind^®; Levodopa/carbidopa; Numient^®; Lumacaftor/Ivacaftor; Orkambi^®; Mepolizumab Nucala^®; Pegaspargasa; Oncaspar^®; Pitolisant; Wakix^®; Sacubitril/Valsartan; Entresto^®; Talimogene Laherparepvec; Imlygic^®.

        · resumen en Español     · texto en Español     · Español ( pdf )